日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase I Study of (131)I-Metaiodobenzylguanidine With Dinutuximab ± Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial.

(131)I-间碘苄胍联合Dinutuximab±Vorinostat治疗复发或难治性神经母细胞瘤患者的I期研究:神经母细胞瘤治疗新方法试验

Cash Thomas, Marachelian Araz, DuBois Steven G, Chi Yueh-Yun, Baregamyan Anahit, Groshen Susan G, Jonus Hunter C, Shamirian Anasheh, Crowley Mary, Goodarzian Fariba, Acharya Patricia T, Pawel Bruce, Erbe Amy K, Shahi Ankita, Zaborek Jen, Kennedy Eleanor, Asgharzadeh Shahab, Villablanca Judith G, Pinto Navin, Weiss Brian D, Mosse Yael P, Desai Ami V, Macy Margaret E, Granger Meaghan, Vo Kieuhoa T, Sondel Paul M, Matthay Katherine K, Park Julie R, Goldsmith Kelly C

Racial and Ethnic Survival Disparities Among Children With High-Risk Neuroblastoma: A Children's Oncology Group Report

儿童肿瘤协作组关于高危神经母细胞瘤患儿种族和民族生存差异的报告

Umaretiya, Puja J; Naranjo, Arlene; Zhang, Fan F; Park, Julie R; Weiss, Brian D; Granger, Meaghan; Desai, Ami V; Ozkaynak, M Fevzi; Yu, Alice L; Aziz-Bose, Rahela; Pruitt, Sandi L; DuBois, Steven G; Bagatell, Rochelle; Bona, Kira

Single-cell and Spatial Omics Reveals Region-Specific Plasticity and Therapeutic Vulnerabilities in Metastatic High-Risk Neuroblastoma

单细胞和空间组学揭示转移性高危神经母细胞瘤的区域特异性可塑性和治疗脆弱性

Wu, Lai Man Natalie; Oblinger, Janet L; Xin, Dazhuan; Rao, Rohit; Zhang, Feng; Adam, Mike; Lopez-Nunez, Oscar; Szabo, Sara; von Allmen, Daniel; Chang, Long-Sheng; Weiss, Brian D; Lu, Q Richard

Cardiac Dysfunction in Children and Young Adults Treated With MEK Inhibitors: A Retrospective, Single-Center Study

MEK抑制剂治疗儿童和青少年心脏功能障碍:一项回顾性单中心研究

Bender, Jonathan D; Pillay-Smiley, Natasha; Hill, Garick D; de Blank, Peter; Hummel, Trent R; Weiss, Brian D; Kumar, Ashish; Zang, Huaiyu; Ollberding, Nicholas J; Ryan, Thomas D

Cbl-b mitigates the responsiveness of naive CD8+ T cells that experience extensive tonic T cell receptor signaling

Cbl-b 可减轻经历大量强直性 T 细胞受体信号传导的幼稚 CD8+ T 细胞的反应性

Joel Eggert, Wendy M Zinzow-Kramer, Yuesong Hu, Elizabeth M Kolawole, Yuan-Li Tsai, Arthur Weiss, Brian D Evavold, Khalid Salaita, Christopher D Scharer, Byron B Au-Yeung

Long-term safety and efficacy of selumetinib in children with neurofibromatosis type 1 on a phase 1/2 trial for inoperable plexiform neurofibromas

一项针对无法手术切除的丛状神经纤维瘤患儿的 1/2 期临床试验,评估了 selumetinib 在 1 型神经纤维瘤病患儿中的长期安全性和有效性

Gross, Andrea M; Dombi, Eva; Wolters, Pamela L; Baldwin, Andrea; Dufek, Anne; Herrera, Kailey; Martin, Staci; Derdak, Joanne; Heisey, Kara S; Whitcomb, Patricia M; Steinberg, Seth M; Venzon, David J; Fisher, Michael J; Kim, AeRang; Bornhorst, Miriam; Weiss, Brian D; Blakeley, Jaishri O; Smith, Malcolm A; Widemann, Brigitte C

Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG)

恩曲替尼用于治疗携带 NTRK、ROS1 或 ALK 异常的实体瘤或原发性中枢神经系统肿瘤的儿童和青少年(STARTRK-NG)

Desai, Ami V; Robinson, Giles W; Gauvain, Karen; Basu, Ellen M; Macy, Margaret E; Maese, Luke; Whipple, Nicholas S; Sabnis, Amit J; Foster, Jennifer H; Shusterman, Suzanne; Yoon, Janet; Weiss, Brian D; Abdelbaki, Mohamed S; Armstrong, Amy E; Cash, Thomas; Pratilas, Christine A; Corradini, Nadège; Marshall, Lynley V; Farid-Kapadia, Mufiza; Chohan, Saibah; Devlin, Clare; Meneses-Lorente, Georgina; Cardenas, Alison; Hutchinson, Katherine E; Bergthold, Guillaume; Caron, Hubert; Chow Maneval, Edna; Gajjar, Amar; Fox, Elizabeth

Selumetinib in children with neurofibromatosis type 1 and asymptomatic inoperable plexiform neurofibroma at risk for developing tumor-related morbidity

Selumetinib 用于患有 1 型神经纤维瘤病和无症状不可手术的丛状神经纤维瘤且有发生肿瘤相关并发症风险的儿童

Gross, Andrea M; Glassberg, Brittany; Wolters, Pamela L; Dombi, Eva; Baldwin, Andrea; Fisher, Michael J; Kim, AeRang; Bornhorst, Miriam; Weiss, Brian D; Blakeley, Jaishri O; Whitcomb, Patricia; Paul, Scott M; Steinberg, Seth M; Venzon, David J; Martin, Staci; Carbonell, Amanda; Heisey, Kara; Therrien, Janet; Kapustina, Oxana; Dufek, Anne; Derdak, Joanne; Smith, Malcolm A; Widemann, Brigitte C

Management of neurofibromatosis type 1-associated plexiform neurofibromas

1型神经纤维瘤病相关丛状神经纤维瘤的治疗

Fisher, Michael J; Blakeley, Jaishri O; Weiss, Brian D; Dombi, Eva; Ahlawat, Shivani; Akshintala, Srivandana; Belzberg, Allan J; Bornhorst, Miriam; Bredella, Miriam A; Cai, Wenli; Ferner, Rosalie E; Gross, Andrea M; Harris, Gordon J; Listernick, Robert; Ly, Ina; Martin, Staci; Mautner, Victor F; Salamon, Johannes M; Salerno, Kilian E; Spinner, Robert J; Staedtke, Verena; Ullrich, Nicole J; Upadhyaya, Meena; Wolters, Pamela L; Yohay, Kaleb; Widemann, Brigitte C

MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus

MEK抑制剂治疗1型神经纤维瘤病:临床证据和共识

de Blank, Peter M K; Gross, Andrea M; Akshintala, Srivandana; Blakeley, Jaishri O; Bollag, Gideon; Cannon, Ashley; Dombi, Eva; Fangusaro, Jason; Gelb, Bruce D; Hargrave, Darren; Kim, AeRang; Klesse, Laura J; Loh, Mignon; Martin, Staci; Moertel, Christopher; Packer, Roger; Payne, Jonathan M; Rauen, Katherine A; Rios, Jonathan J; Robison, Nathan; Schorry, Elizabeth K; Shannon, Kevin; Stevenson, David A; Stieglitz, Elliot; Ullrich, Nicole J; Walsh, Karin S; Weiss, Brian D; Wolters, Pamela L; Yohay, Kaleb; Yohe, Marielle E; Widemann, Brigitte C; Fisher, Michael J